A phase I/II study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for recurrent glioblastoma. Study Group on Gene Therapy for Glioblastoma.

Klatzmann, D; Valéry, C A; Bensimon, G; Marro, B; Boyer, O; Mokhtari, K; Diquet, B; Salzmann, J L; Philippon, J

Klatzmann, D; Valéry, C A; Bensimon, G; Marro, B; Boyer, O; Mokhtari, K; Diquet, B; Salzmann, J L; Philippon, J.

Affiliation

Klatzmann D; Department of Immunology, Hôpital Pitié-Salpêtrière, Paris, France.

Hum Gene Ther ; 9(17): 2595-604, 1998 Nov 20.

Article in En | MEDLINE | ID: mdl-9853526

Subject(s)

Brain Neoplasms/therapy; Glioblastoma/therapy; Herpesvirus 1, Human/genetics; Thymidine Kinase/genetics; Adult; Brain Neoplasms/diagnostic imaging; Disease-Free Survival; Female; Ganciclovir/therapeutic use; Glioblastoma/diagnostic imaging; Herpesvirus 1, Human/enzymology; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radiography; Recurrence

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thymidine Kinase / Brain Neoplasms / Herpesvirus 1, Human / Glioblastoma Type of study: Diagnostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Hum Gene Ther Journal subject: GENETICA MEDICA / TERAPEUTICA Year: 1998 Type: Article Affiliation country: France

Search on Google

XML

PubMed Links